Ledger.Open graph →
SEC Form D · filed August 4, 2015

Ankasa Regenerative Therapeutics, Inc

Offering
$20.0M
Sold
$9.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LA JOLLA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Douglas J. Downs · La Jolla, CAExec · DirectorSanford J. Madigan · La Jolla, CAExec · DirectorKevin J. Kinsella · La Jolla, CADirectorDouglas J. Downs · La Jolla, CAExec · DirectorKevin J. Kinsella · La Jolla, CADirectorSanford J. Madigan · La Jolla, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗